In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.
Only logged in customers who have purchased this product may leave a review.
You may also like
Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Artificial Intelligence in Life Sciences$0.00 LEK
To get a sense of the potential of digitization in procurement, picture this: It’s 2020. Hybrid cloud solutions, RPA and blockchain are in place. P2P is highly streamlined with zero-touch options. As a next-gen Chief Procurement Officer, your day starts with browsing through a virtual supplier screen that displays a status report on expiring contracts, feedback from suppliers on contractual negotiations, RFX launched on open markets and so on.
Procurement 4.0 Preparing for Digital Transformation$0.00 ORBIT2transformation
In this year’s State of Financial Services report we examine the potential for the industry to start again. We explore the power of new – areas in the industry where new technology and businesses are having a proven impact. We show how existing firms can deploy a greenfield approach to deliver new growth and to accelerate transformation of the existing business.
The State of the Financial Services Industry 2019: Time to Start againRated 4.00 out of 5$0.00 Oliver Wyman
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?